3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Endocrine
1
Conditions
Breast Neoplasms
51
Neoplasms
34
Colorectal Neoplasms
23
Lung Neoplasms
17
Prostatic Neoplasms
16
Melanoma
15
Neoplastic Cells, Circulating
13
Pancreatic Neoplasms
11
Multiple Myeloma
11
Uterine Cervical Neoplasms
10
Ovarian Neoplasms
10
Carcinoma, Non-Small-Cell Lung
8
Papillomavirus Infections
7
Neoplasm Metastasis
7
Leukemia, Myeloid, Acute
7
Colonic Neoplasms
7
Lymphoma, Follicular
6
Lymphoma
6
Hematologic Neoplasms
6
Uveal Melanoma
5
Sarcoma
5
Head and Neck Neoplasms
5
Glioma
5
Uterine Cervical Dysplasia
4
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioblastoma
4
Disease
4
COVID-19
4
Interventions
ribociclib
1
napabucasin
1
bosutinib
1
amrubicin
1
Sunitinib
1
Radiosurgery
1
Quality of Life
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Erlotinib Hydrochloride
1
Drug Therapy
1
Cisplatin
1
Blood Specimen Collection
1
Biological Therapy
1
Bevacizumab
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thymus Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT01794676
2017-06-16
MEN1
Jersey Shore University Medical Center
Completed
9 enrolled